Using phenol for treating pilonidal sinus: a systematic review and meta-analysis

Hagiga, Ahmed; Aly, Mohamed; Gultiaeva, Mariia; Murphy, Henry C.

doi:10.1007/s00238-019-1499-3

Cited by 2 publications

(3 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Therefore, Yuksel explained the crystallized phenol technique in detail to encourage dermatologists to treat PSD in the outpatient clinic (22). Also, CP application eliminates the cost of hospitalization and possible complications of surgery and anesthesia (23).…”

Section: Discussionmentioning

confidence: 99%

Efficacy of Minimally Invasive Crystallized Phenol Application in the Treatment of Pilonidal Sinus in Children

Dayı

Sancar

ANAYURT>

2023

Pediatric Practice and Research

View full text Add to dashboard Cite

Background/Aims: Pilonidal sinus treatment involves surgical excision or flap reconstruction; however, the disease has a high recurrence risk. We determined the outcomes of a modified local application of crystallized phenol. Methods: In the outpatient clinic, the pilonidal sinus orifices were connected by an incision under local anesthesia. The hair in the sinus was removed. Then, crystallized phenol was applied. The incision was not sutured. Daily dressings and baths were recommended. Results: Crystallized phenol was applied to 50 patients with pilonidal sinus disease (median age = 15 years). During the follow-up, no bleeding or pain was reported. Recurrence was not found in the follow-ups (one year to three years). Conclusions: Surgery has disadvantages such as long-term hospitalization, recurrence risk, and high cost. Crystallized phenol does not have any of the aforementioned disadvantages. The modified method, in which we incised and applied crystallized phenol to all sinus tracts, might have also reduced the recurrence.

show abstract

Section: Discussionmentioning

confidence: 99%

Efficacy of Minimally Invasive Crystallized Phenol Application in the Treatment of Pilonidal Sinus in Children

Dayı

Sancar

ANAYURT>

2023

Pediatric Practice and Research

View full text Add to dashboard Cite

show abstract

“…Our results agree with those reported in other studies. 15,17,21,32,33 Therefore, in our experience, it is possible to start and phenol protocol in selected SPD with an experienced team. Several studies showed a reduction of return normal activity in selected patients.…”

Section: Discussionmentioning

confidence: 99%

“…Several studies showed a reduction of return normal activity in selected patients. 32 , 34 We have shown that phenolization protocol in the SPD is safe in selected patients, due to the improvement in terms of quality of care, clinical and potential economic benefits, and a significant reduction of sick leave.…”

Section: Discussionmentioning

confidence: 99%

Randomised clinical trial to test the phenolization in sacrococcygeal pilonidal disease

López

Perez

Mallafré

et al. 2023

International Wound Journal

View full text Add to dashboard Cite

To test the efficacy and safety of phenolization in uncomplicated Sacrococcygeal pilonidal disease (SPD) the phenolization in uncomplicated SPD is feasible and secure in selected patients in observational studies. The greatest benefits are obtained to reduce the length of sick leave (LSL) and complications. Single-center randomised controlled clinical trial. Patients were recruited at University Hospital of Tarragona Joan XXIII of Spain. Patients were randomised into two treatment groups. All patients with uncomplicated sacrococcygeal disease, localised in the midline and with only 1 fistulous orifice. The patients were randomly assigned to the phenolization group (PhG) or conventional-surgery group (CsG). Both groups were managed without admission. The main endpoint was the recurrence of sacrococcygeal disease. Secondary endpoints included time of sick leave, complications, and readmission. 124 patients were included in the study. No disease recurrence was observed in either group. Clinical follow-up was carried out with a mean of 493.8 days (SD 6.59). The LSL was shorter in the PhG (mean 19.63 days, SD 28.15) than in the CSG (43.95 days, SD 38.60). The LSL reduction was À24.31 days (P .002). The phenolization in selected SPD is a safe and feasible procedure in selected patients. This approach could become the standard of care for patients with selected Sacrococcygeal pilonidal.

show abstract

Using phenol for treating pilonidal sinus: a systematic review and meta-analysis

Cited by 2 publications

References 13 publications

Efficacy of Minimally Invasive Crystallized Phenol Application in the Treatment of Pilonidal Sinus in Children

Efficacy of Minimally Invasive Crystallized Phenol Application in the Treatment of Pilonidal Sinus in Children

Randomised clinical trial to test the phenolization in sacrococcygeal pilonidal disease

Contact Info

Product

Resources

About